Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Enterprise Value : 6.302B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.302B |
| November 12, 2026 | 6.565B |
| November 11, 2026 | 6.717B |
| November 10, 2026 | 6.700B |
| November 09, 2026 | 7.027B |
| November 06, 2026 | 6.930B |
| November 05, 2026 | 7.159B |
| November 04, 2026 | 9.220B |
| November 03, 2026 | 9.114B |
| November 02, 2026 | 8.899B |
| October 30, 2026 | 9.539B |
| October 29, 2026 | 10.06B |
| October 28, 2026 | 9.860B |
| October 27, 2026 | 9.349B |
| October 26, 2026 | 9.001B |
| October 23, 2026 | 8.871B |
| October 22, 2026 | 8.787B |
| October 21, 2026 | 8.971B |
| October 20, 2026 | 8.615B |
| October 19, 2026 | 8.501B |
| October 16, 2026 | 8.458B |
| October 15, 2026 | 8.802B |
| October 14, 2026 | 8.370B |
| October 13, 2026 | 8.162B |
| October 12, 2026 | 8.208B |
| Date | Value |
|---|---|
| October 09, 2026 | 8.211B |
| October 08, 2026 | 7.580B |
| October 07, 2026 | 7.466B |
| October 06, 2026 | 7.567B |
| October 05, 2026 | 8.409B |
| October 02, 2026 | 7.810B |
| October 01, 2026 | 7.824B |
| September 30, 2026 | 8.478B |
| September 29, 2026 | 8.575B |
| September 28, 2026 | 8.631B |
| September 25, 2026 | 8.696B |
| September 24, 2026 | 8.778B |
| September 23, 2026 | 8.603B |
| September 22, 2026 | 8.552B |
| September 21, 2026 | 8.320B |
| September 18, 2026 | 8.131B |
| September 17, 2026 | 8.397B |
| September 16, 2026 | 7.631B |
| September 15, 2026 | 7.713B |
| September 14, 2026 | 7.021B |
| September 11, 2026 | 6.537B |
| September 10, 2026 | 6.453B |
| September 09, 2026 | 6.450B |
| September 08, 2026 | 6.673B |
| September 04, 2026 | 6.744B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 45.20B |
| Myriad Genetics, Inc. | 643.96M |
| BioRestorative Therapies, Inc. | -1.659M |
| CareDx, Inc. | 3.864B |
| Exagen, Inc. | 105.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.25M |
| Revenue (Quarterly) | 275.36M |
| Total Expenses (Quarterly) | 260.11M |
| EPS Diluted (Quarterly) | 0.0517 |
| Gross Profit Margin (Quarterly) | 66.20% |
| Profit Margin (Quarterly) | 5.54% |
| Earnings Yield | 1.47% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.758 |